OTC day traders and short term penny stock players will want to pay close attention to patent protected dermatology and healthcare products developer Skinvisible Inc. (OTC: SKVI). The Company already has an established foothold in the skin care product market and just recently raised $1 million, enough to get it through about nine months. With a cheap share price stuck at 0.035 for a week and a booming industry, SKVI stock should be on the watch list as a great play this week, maybe even for the rest of the month.
Our Next Pick Is Coming Soon! Click HERE To Make Sure You Don’t Miss Any Of Our Breaking Alerts!
SKVI Stock Chart
Market Cap: 3.81M
Last: 0.035 (unchanged)
Issued and Outstanding: 108,736,909
14-Day Rel Strength: 49.56%
14-Day Stochastic: 44.44%
Looking for Hot Penny Stocks?
Click here To Receive FREE Penny Stock Alerts
Last year was a rough one for Skinvisible as they had to begin the year having just renegotiated accrued salaries and interest for three employees and repeat the process again in June, 2012. Sales for 2012 just weren’t enough to put the skin care focused Company into the “black” having lost a little more than $1 million for the nine months ended September 30, 2012 versus slightly less than $800K for the same period in 2011.
The future however looks much brighter for the Company, a good reason why SKVI stock should be on the watch list today and the remainder of the month.
Skinvisible has 8 global licensees, 3 of which are currently in the marketplace (Avon Products globally, Women’s Choice Pharmaceuticals in the U.S. and Alto Pharmaceuticals in Canada) with 4 licensees which have 6 products in total being prepared for launch in 2013. All in all, the Company has a pipeline of over 40 products which are available for licensing after having been tested in-house generating proof of concept including release of the active ingredient as well as long term shelf life.
Sales may have dropped of for the nine months ended September 30, 2012 compared to the same period the year prior, but SKVI stock seems to have skidded at its bottom and looks poised for a break out worth watching.
About SKVI Stock
Skinvisible Inc., through their wholly owned subsidiary Skinvisible Pharmaceuticals Inc., are a pharmaceutical research and development company that has developed and patented an innovative polymer delivery system, Invisicare® and formulated over forty topical skin products which the Company out-license globally. Click here to view the SEC filings for SKVI.
Last 5 Trading Sessions:
Bottom Line: SKVI stock presents penny stock traders an opportunity to scoop up some cheap shares at what looks like the bottom. With some decent momentum and shares of SKVI stock having been distributed at $0.04 during the last few months, traders could see a nice return on a short-term rally without losing their skivvies.
Here is your opportunity to subscribe to the Most Read Penny Stock Newsletter
If You Can’t Make Money With Us, You Shouldn’t Be Trading Penny Stocks
(We are 100% Anti-Spam and will never rent or sell your information)Share